Yahoo Web Search

Search results

  1. People also ask

  2. 6 hours ago · Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal ... Ty Roush is a breaking news reporter based in New York City. ... roughly 79% more than the company’s closing price on ...

  3. 2 hours ago · Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes ...

  4. 3 hours ago · Eli Lilly and Company (NYSE:LLY), the world's largest pharmaceutical company by market cap, announced today that it is set to acquire Morphic Holding, Inc. (NASDAQ:MORF), the Waltham ...

  5. 6 hours ago · Eli Lilly agreed to buy biopharmaceutical firm Morphic for roughly $3.2 billion, sending shares of Morphic skyrocketing Monday. ... News; Company News; Eli Lilly Buys Morphic for $3.2B. By Andrew ...

  6. 4 hours ago · Eli Lilly and Co. is buying a Waltham biotech in a deal valued at around $3.2 billion. The startup being acquired is Morphic Holding Inc. (NASDAQ: MORF), a Waltham company working on treatments ...

  7. 3 hours ago · Eli Lilly and Company is set to acquire Morphic Holding for $3.2bn. Morphic is focused on autoimmune disease drugs. Morphic's MORF-057 has a similar MoA to Takeda's ~$5bn per annum selling drug entyvio, but it is orally available, unlike the injectable entyvio.

  8. 19 hours ago · Jul 8, 2024 11:15am. By Colin Kellaher. Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker's immunology pipeline. Eli ...

  1. People also search for